Cite
HARVARD Citation
Zhu, F. et al. (n.d.). Efficacy, immunogenicity and safety of the AS04‐HPV‐16/18 vaccine in Chinese women aged 18‐25 years: End‐of‐study results from a phase II/III, randomised, controlled trial. Cancer medicine. pp. 6195-6211. [Online].